Edy Mustofa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Edy Mustofa has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- I. Wayan Arsana Wiyasa
Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
1 shared publication - Muhammad Anas
Universitas Muhammadiyah Surabaya
1 shared publication Sri Poeranto
Medical Faculty Parasitology Laboratory Brawijaya University 65145 Malang East Java Indonesia
1 shared publication- Sumarno
Department of Microbiology, Faculty of Medicine, Universitas Brawijaya / Dr. Saiful Anwar General Hospital, Malang, Indonesia
1 shared publication - Tatit Nurseta
Obstetric Gynecology Laboratory Medical Faculty Brawijaya University 65145 Malang East Java Indonesia
1 shared publication - Umi Kalsum
Medical Faculty Pharmacology Laboratory Brawijaya University 65145 Malang East Java Indonesia
1 shared publication
Latest Publications
- Open Access
- 1 November 2024
- Published by Brazilian Journals in Journal of Lifestyle and SDGs Review
- Vol. 5 (2) , e02739
Induction of an 11 KDA Protein Epitope For Reducing Mrsa Bacterial Colony Counts Via Cellular and Humoral Adaptive Immune Responses In Postpartum MUS Musculus Infected With MRSA: A Strategy for Enhancing Public Health and Combating Antibiotic Resistance
Objective: This study investigates how the 11 kDa protein epitope, from the cross-reaction between MRSA bacteria and L. reuteri, reduces MRSA colonies through adaptive immune responses (Th17, Th2), cytokines (IL-4, IL-22), and innate immunity (IgG antibodies) in postpartum Mus musculus. Method: A true experimental design was applied using Balb/c mice divided into seven groups, including controls and those treated with different combinations of L. reuteri, MRSA proteins, and peptides. Cellular immunity (Th17, Th2), cytokines (IL-4, IL-22), IgG antibodies, and MRSA colonies were measured post-treatment. Results & Discussion: The candidate vaccine enhanced cellular adaptive immunity (Th2, Th17), cytokine responses (IL-4, IL-22), and reduced MRSA colonies. IgG levels were notably higher in Groups K3 and K6 compared to K1. Conclusion: The 11 kDa protein epitope, from the MRSA-L. reuteri cross-reaction, effectively modulates adaptive immunity, reducing MRSA colonies in postpartum Mus musculus.
- 1 November 2024
- Published by Brazilian Journals in Journal of Lifestyle and SDGs Review
- Vol. 5 (2) , e02739
Open AccessInduction of an 11 KDA Protein Epitope For Reducing Mrsa Bacterial Colony Counts Via Cellular and Humoral Adaptive Immune Responses In Postpartum MUS Musculus Infected With MRSA: A Strategy for Enhancing Public Health and Combating Antibiotic Resistance
Objective: This study investigates how the 11 kDa protein epitope, from the cross-reaction between MRSA bacteria and L. reuteri, reduces MRSA colonies through adaptive immune responses (Th17, Th2), cytokines (IL-4, IL-22), and innate immunity (IgG antibodies) in postpartum Mus musculus. Method: A true experimental design was applied using Balb/c mice divided into seven groups, including controls and those treated with different combinations of L. reuteri, MRSA proteins, and peptides. Cellular immunity (Th17, Th2), cytokines (IL-4, IL-22), IgG antibodies, and MRSA colonies were measured post-treatment. Results & Discussion: The candidate vaccine enhanced cellular adaptive immunity (Th2, Th17), cytokine responses (IL-4, IL-22), and reduced MRSA colonies. IgG levels were notably higher in Groups K3 and K6 compared to K1. Conclusion: The 11 kDa protein epitope, from the MRSA-L. reuteri cross-reaction, effectively modulates adaptive immunity, reducing MRSA colonies in postpartum Mus musculus.